ABBOTT LABORATORIES (ABT)
US0028241000 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.90B | 9.88B | 9.80B | 6.84B | 3.86B | |||
| Marketable Securities | 383.00M | 288.00M | 450.00M | 310.00M | 280.00M | |||
| Receivables | 6.57B | 6.22B | 6.49B | 6.41B | 5.42B | |||
| Inventories | 6.57B | 6.17B | 5.16B | 5.01B | 4.32B | |||
| Other Current Assets | 2.26B | 2.66B | 2.35B | 1.87B | 1.79B | |||
| Total Current Assets | 22.67B | 25.22B | 24.24B | 20.44B | 15.67B | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.28B | 10.28B | 10.11B | 10.13B | 8.97B | |||
| Investments And Advances | 799.00M | 766.00M | 816.00M | 821.00M | 883.00M | |||
| Goodwill | 23.68B | 22.80B | 23.23B | 23.74B | 23.20B | |||
| Intangibles | 8.81B | 10.45B | 12.74B | 14.78B | 17.02B | |||
| Other Non-Current Assets | 5.97B | 4.92B | 4.06B | 2.63B | 2.15B | |||
| Total Non-Current Assets | 50.54B | 49.21B | 50.96B | 52.11B | 52.22B | |||
| TOTAL ASSETS | 73.21B | 74.44B | 75.20B | 72.55B | 67.89B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 213.00M | 201.00M | |||
| Current Portion Of LT Debt. | 1.08B | 2.25B | 754.00M | 7.00M | 1.28B | |||
| Accrued Expenses | 7.02B | 7.40B | 6.81B | 6.58B | 5.18B | |||
| Accounts Payable | 4.29B | 4.61B | 4.41B | 3.95B | 3.25B | |||
| Other Current Liabilities | 1.45B | 1.23B | 1.14B | 1.16B | 950.00M | |||
| Total Current Liabilities | 13.84B | 15.49B | 13.11B | 11.91B | 10.86B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 13.60B | 14.52B | 17.30B | 18.53B | 16.11B | |||
| Deferred Taxes/Income | 568.00M | 991.00M | 1.39B | 1.41B | 1.55B | |||
| Other Non-Current Liabilities | 6.38B | 6.53B | 7.38B | 7.71B | 8.06B | |||
| Total Non-Current Liabilities | 20.77B | 22.26B | 26.29B | 27.86B | 25.94B | |||
| TOTAL LIABILITIES | 34.61B | 37.75B | 39.39B | 39.76B | 36.80B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 37.55B | 35.26B | 31.53B | 27.63B | 25.85B | |||
| Minority Interest | 224.00M | 219.00M | 222.00M | 219.00M | 213.00M | |||
| Common Shares | 24.87B | 24.71B | 24.47B | 24.14B | 23.85B | |||
| Treasury Stock | -15.98B | -15.23B | -11.82B | -10.04B | -10.15B | |||
| Other Shareholders' Equity | -7.84B | -8.05B | -8.37B | -8.95B | -8.46B | |||
| Shares Outstanding | 1.73B | 1.74B | 1.76B | 1.77B | 1.76B | |||
| Tangible Book Value per Share | 3.52 | 1.98 | -0.10 | -3.24 | -5.18 | |||
| Total Shareholders' Equity | 38.60B | 36.69B | 35.80B | 32.78B | 31.09B | |||
| TOTAL LIABILITIES AND EQUITY | 73.21B | 74.44B | 75.20B | 72.55B | 67.89B | |||
| Statistics | ||||||||
| Debt/Equity | 0.35 | 0.40 | 0.48 | 0.57 | 0.52 | |||
| Current Ratio | 1.64 | 1.63 | 1.85 | 1.72 | 1.44 | |||
| Return On Assets (ROA) | 7.82% | 9.31% | 9.40% | 6.20% | 5.43% | |||
| Return On Equity (ROE) | 14.83% | 18.90% | 19.75% | 13.71% | 11.86% | |||
| Return On Invested Capital (ROIC) | 9.59% | 12.51% | 11.71% | 7.56% | 6.91% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 10.93% | 15.11% | 14.03% | 8.56% | 7.45% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 29.04% | 47.49% | 45.82% | 30.29% | 30.74% | |||
All data in USD